CHR-6494 is a potent and selective histone kinase Haspin inhibitor. CHR-6494 reduces H3T3ph levels in a dose-dependent manner and causes a mitotic catastrophe characterized by metaphase misalignment, spindle abnormalities and centrosome amplification. CHR-6494 shows antitumor potential in xenografted nude mice without any observed toxicity. Thus, CHR-6494 is a first-in-class Haspin inhibitor with a wide spectrum of anticancer effects that merits further preclinical research as a new member of the family of mitotic kinase inhibitors.
MedKoo Cat#: 406782
Name: CHR-6494
CAS#: 1333377-65-3 (free base)
Chemical Formula: C16H16N6
Exact Mass: 292.1436
Molecular Weight: 292.35
Elemental Analysis: C, 65.74; H, 5.52; N, 28.75
Solvent | mg/mL | mM | comments | |
---|---|---|---|---|
Solubility | ||||
DMF | 12.5 | 42.76 | ||
DMSO | 20.0 | 68.41 | ||
Ethanol | 0.3 | 0.86 |
The following data is based on the product molecular weight 292.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |